Vasopressin Receptor Antagonists in Hyponatremia: Uses and Misuses.

Front Med (Lausanne) · 2017 · PMC5573438 · PMID 28879182

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Patients in the tolvaptan group compared to placebo showed a highly significant improvement in PNa by day 4 (5 vs. −0.3 mmol/L) and by day 30 (6.9 vs. 1 mmol/L).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.